News
greater control over the biotech company’s operations. Pete Salzmann, Immunovant’s current CEO and board member, is retiring. He will be replaced by Eric Venker, Roivant’s current president ...
Analysts exoect revenue to rise by more than 180%, to $762 million, this year, and then grow another 45%, to $1.1 billion, next year, pushing the biotech company out of the red and into the black ...
President Trump signs an executive order to streamline pharmaceutical plant approvals and boost domestic manufacturing ...
Tilt your stock portfolio toward biotech companies now and you could stand to make substantial profits in the near future. You can also find cost-effective stocks under $20 to trade daily on the ...
DOHA: Qatar Free Zones Authority (QFZ) and BIOCAD– one of Russia’s leading biotechnology companies – yesterday signed a landmark Memorandum of Understanding, paving the way for the ...
The Federal Trade Commission on Monday sued Uber, accusing the ride-hailing and delivery company of deceptive billing and cancellation practices tied to its subscription service. The agency ...
Novo Nordisk has agreed its second acquisition in the space of a month of a biotech in the obesity category, snapping up fellow Danish company Embark Biotech for €15 million (around $16 million ...
The biotech is a specialist in messenger RNA technology, using mRNA to teach the body to make certain proteins that fight or protect against disease. The company's pipeline -- spanning programs ...
In a more recent escalation of this confrontation, the BIOSECURE Act was tabled in the US, which aims to prevent the contracting or extension of loans and grants with a “biotechnology company of ...
German COVID-19 vaccine maker BioNTech said on Monday that Ramon Zapata-Gomez will become its new finance chief from July 1.
Get prepared with the key expectations. Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results